1. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.
- Author
-
Rabinowitz J, Katz IR, De Deyn PP, Brodaty H, Greenspan A, and Davidson M
- Subjects
- Aged, Aggression drug effects, Aggression psychology, Alzheimer Disease diagnosis, Alzheimer Disease drug therapy, Alzheimer Disease psychology, Dementia, Vascular diagnosis, Dementia, Vascular drug therapy, Dementia, Vascular psychology, Female, Humans, Male, Mental Disorders diagnosis, Nursing Homes statistics & numerical data, Personality Inventory, Placebos, Psychiatric Status Rating Scales, Psychomotor Agitation drug therapy, Psychomotor Agitation psychology, Treatment Outcome, Antipsychotic Agents therapeutic use, Dementia drug therapy, Dementia psychology, Mental Disorders drug therapy, Mental Disorders psychology, Risperidone therapeutic use
- Abstract
Objective: To examine the effect of risperidone on specific behavioral and psychological symptoms of dementia (BPSD)., Method: We conducted a post hoc exploratory analysis of an integrated database from 3 randomized, controlled trials of risperidone versus placebo in treating 1150 nursing home residents with BPSD. Changes in scores were measured for items on the Cohen-Mansfield Agitation Inventory (CMAI) and Behavioral Pathology in Alzheimer's Disease Rating Scale (BEHAVE-AD)., Results: On the CMAI, risperidone was significantly more effective in treating hitting (p = .000), hurt self or other (p = .005), cursing or verbal aggression (p = .000), repetitive sentences or questions (p = .001), scratching (p = .041), general restlessness (p = .001), grabbing onto people (p = .028), constant request for attention (p = .041), pacing and aimless wandering (p = .013), and performing repetitious mannerisms (p = .045). On the BEHAVE-AD, risperidone was significantly more effective in treating physical threats and/or violence (p = .000), verbal outbursts (p = .000), other anxieties (p = .01), agitation (p = .000), tearfulness (p = .03), and nonparanoid delusions (p = .02)., Conclusions: The items from the BEHAVE-AD and CMAI that were improved with risperidone included psychotic, agitated, and aggressive symptoms. These data suggest that risperidone is more effective than placebo in treating a variety of symptoms associated with dementia.
- Published
- 2004
- Full Text
- View/download PDF